Trending
April 1, 2024

NRx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

April 1, 2024

Carisma Therapeutics Appoints John Hohneker, M.D. to the Board of Directors

April 1, 2024

Healthiest Cities in America (2024 Rankings) – WalletHub Study

March 28, 2024

NRx Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

March 28, 2024

NRx Pharmaceuticals Announces Reverse Stock Split

March 28, 2024

Tonix Pharmaceuticals Prices of $4.4 Million Registered Direct Offering

March 27, 2024

Dr. Mia Talmor Joins the MTF Biologics Board of Directors

March 27, 2024

Tevogen Bio Announces Series A-1 Preferred Stock Investment

March 27, 2024

Carmell Closes Sale of Axolotl Biologix

March 26, 2024

Highmark Health Appoints Craig Riner as Executive Vice President, Chief Marketing Officer

March 26, 2024

BD Named Among Fortune’s Most Innovative Companies

March 26, 2024

Virpax Pharmaceuticals Reports 2023 Year-End Results

March 26, 2024

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

March 26, 2024

Orchestra BioMed Appoints David Pacitti To Board

March 26, 2024

Healthcare Advisory Firm Coker Group Sells Majority Stake to PE Firm Trinity Hunt Partners

March 25, 2024

NRx Pharmaceutical’s Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK